Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2014
08/28/2014WO2014130218A1 Three dimensional structural support for female pelvic organs in thong underwear
08/28/2014WO2014130068A1 Methods for increasing oral ostenogenesis using lipoxin a4 (lxa4) and its analogs
08/28/2014WO2014130016A1 Drug combinations to treat liver cancer
08/28/2014WO2014128661A1 Oral formulation and suspension of an oncology drug
08/28/2014WO2014128564A2 Pharmaceutical compositions of cetp inhibitors
08/28/2014WO2014128233A1 Oral steroid formulations for use in the treatment of intestinal fibrosis
08/28/2014WO2014128209A1 Pharmaceutical formulation comprising dpp-iv inhibitor agglomerates
08/28/2014WO2014128116A1 A production process for gliclazide formulations
08/28/2014WO2014128107A1 Pharmaceutical composition comprising n-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof
08/28/2014WO2014128079A1 Glatiramer acetate multidose formulation
08/28/2014WO2014127802A1 Stable compositions of bendamustine
08/28/2014WO2014127786A1 Orally disintegrating pharmaceutical composition comprising asenapine
08/28/2014WO2014127475A1 Therapeutic composition for the treatment perianal disorders
08/28/2014WO2014127459A1 Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
08/28/2014WO2014127458A1 Pharmaceutical composition for transmucosal administration of benzodiazepines
08/28/2014WO2014100418A3 Orally disintegrating tablet formulation for enhanced bioavailability
08/28/2014WO2014081343A3 Pharmaceutical composition containing nalbuphine hydrochloride, use thereof to treat moderate to severe pain and method for producing said pharmaceutical composition
08/28/2014WO2014047486A3 Spray drying microcapsules
08/28/2014WO2013114011A8 Transdermal device for the controlled administration of at least one active ingredient to a patient
08/28/2014US20140243794 Device and method for delivering a dose of medicament comprising activated carbon particles
08/28/2014US20140243765 Percutaneously absorbable preparation containing fentanyl and homologue thereof
08/28/2014US20140243764 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
08/28/2014US20140243427 Process for Preparing a Synthetic Foam Having a Controlled Particle Distribution
08/28/2014US20140243416 Topical Antiandrogen Therapy for the Treatment of Becker's Nevus
08/28/2014US20140243413 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/28/2014US20140243379 Adhesive mixture for transdermal delivery of highly plasticizing drugs
08/28/2014US20140243364 Enhanced stability of novel liquid compositions
08/28/2014US20140243358 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
08/28/2014US20140243304 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
08/28/2014US20140243299 Topical Formulations of Corticosteroids with Enhanced Bioavailability
08/28/2014US20140243296 Organic Compounds
08/28/2014US20140243262 Pharmaceutical formulations containing an sglt2 inhibitor
08/28/2014US20140242256 Nano-encapsulated, controlled drug delivery, manufacturing process and system
08/28/2014US20140242180 Nanoparticles for controlling bleeding and drug delivery
08/28/2014US20140242179 Novel coating system
08/28/2014US20140242178 Taste-masked formulations of raltegravir
08/28/2014US20140242177 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
08/28/2014US20140242176 Compositions, methods, and devices for the treatment of eye stain
08/28/2014US20140242175 Nano-encapsulated, controlled drug delivery, manufacturing process and system
08/28/2014US20140242174 Treating cough and tussive attacks
08/28/2014US20140242171 Oil-in-water emulsion of mometasone and propylene glycol
08/28/2014US20140242169 Tapentadol compositions
08/28/2014US20140242168 Swellable coated tablet
08/28/2014US20140242167 Pharmaceutical compositions for glucocorticoid replacement therapy
08/28/2014US20140242166 Sustained release matrix systems for highly soluble drugs
08/28/2014US20140242165 Biocompatible Carrier Containing A Bioadhesive Material
08/28/2014US20140242162 Pharmaceutical compositions comprising 40 - o - ( 2 - hydroxy) ethyl - rapamycin
08/28/2014US20140242161 Soft gelatin capsules
08/28/2014US20140242160 Calcium supplement
08/28/2014US20140242159 Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients
08/28/2014US20140242158 Granular Pharmaceutical Composition
08/28/2014US20140242157 Epicatechin compositions and methods
08/28/2014US20140242156 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
08/28/2014US20140242153 Novel encochleation methods, cochleates and methods of use
08/28/2014US20140242151 Adhesive skin patch
08/28/2014US20140242147 Adsorbents for oral administration
08/28/2014US20140242146 Filament based on hyaluronic acid in the form of free acid and method for obtaining it
08/28/2014US20140242145 Chitosan nanofiber for anionic protein drug delivery, method of preparing the same, and pharmaceutical preparation for transmucosal administration comprising the chitosan nanofiber
08/28/2014US20140242139 Controlled drug delivery
08/28/2014US20140242138 Applications Of Microencapsulated Essential Oils
08/28/2014US20140242123 Saccharide-peptide hydrogels
08/28/2014US20140242064 Methods and apparatus for delivering a therapeutic agent to nasopharyngeal mucosa targets
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/28/2014US20140242043 Methods for preventing or treating optic neuritis
08/28/2014US20140242040 Methods for preventing and/or treating nasal polyps and rhinosinusitis
08/28/2014US20140242023 Topical Compositions and Methods of Using the Same
08/28/2014US20140242012 Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
08/28/2014US20140241998 Body cavity foams
08/28/2014US20140241996 Therapeutic nanoparticles and methods of use thereof
08/28/2014US20140239526 Process for producing pellets for pharmaceutical compositions
08/28/2014US20140239525 Inhalable pharmaceutical compositions
08/28/2014DE112012005185T5 Transdermales Verabreichungssystem The transdermal delivery system
08/27/2014EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
08/27/2014EP2769719A1 Formulations of radioprotective alpha, beta unsaturated aryl sulfones
08/27/2014EP2769718A1 Medicinal composition
08/27/2014EP2769717A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof
08/27/2014EP2769714A1 Transdermal therapeutic system for administering the active substance buprenorphine
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2769712A1 Pharmaceutical formulation comprising DPP-IV inhibitor agglomerates and DPP-IV inhibitor particles
08/27/2014EP2769711A1 Methods and Compositions for Enhanced Delivery of Macromolecules
08/27/2014EP2768958A1 Amine cationic lipids and uses thereof
08/27/2014EP2768606A1 Method of forming fine particles of a drug substance
08/27/2014EP2768537A2 Acrylic polymer formulations
08/27/2014EP2768511A1 Improvements in or relating to organic compounds
08/27/2014EP2768508A1 Solution for oral administration
08/27/2014EP2768490A1 Stabilizers for hemostatic products
08/27/2014EP2768489A1 Pharmaceutical compositions of resveratrol
08/27/2014EP2768488A1 Two phase pharmaceutical delivery system
08/27/2014EP2768487A1 Sustained-release preparation
08/27/2014EP2768486A1 Tocotrienol compositions
08/27/2014EP2768485A1 Pharmaceutical nanosuspension
08/27/2014EP2768484A1 Lyophilized liposomes
08/27/2014EP2768483A1 Pharmaceutical composition comprising nanocrystals
08/27/2014EP2768482A1 Anti-tumoral compound and relative production process
08/27/2014EP2768481A1 Compositions for reduction of side effects
08/27/2014EP2768480A1 Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one) -6-yl]-5-fluoro-n2- [3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
08/27/2014EP2768479A1 Excipients for nicotine-containing therapeutic compositions
08/27/2014EP2768478A1 Paste comprising non-steroidal anti-inflammatory
08/27/2014EP2768477A1 Nicotine chewing gum with improved utilization of nicotine
08/27/2014EP2768471A2 Aqueous dispersion having a content of lipid nanoparticles, process for production thereof and use thereof
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 2991